TY - JOUR T1 - Links between air pollution and COVID-19 in England JF - medRxiv DO - 10.1101/2020.04.16.20067405 SP - 2020.04.16.20067405 AU - Marco Travaglio AU - Rebeka Popovic AU - Yizhou Yu AU - Nuno Santos Leal AU - Luis Miguel Martins Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/04/17/2020.04.16.20067405.abstract N2 - In December 2019 a novel disease coronavirus disease 19 (COVID-19) emerged in the Wuhan province of the People’s Republic of China. COVID-19 is caused by a novel coronavirus (SARS-CoV-2) thought to have jumped species, from another mammal to humans. A pandemic caused by this virus is running rampant throughout the world. Thousands of cases of COVID-19 are reported in England and over 10,000 patients have died. Whilst there has been progress in managing this disease, it is not clear which factors, besides age, affect the severity and mortality of COVID-19. A recent analysis of COVID-19 in Italy identified links between air pollution and death rates. Here, we explored the correlation between three major air pollutants linked to fossil fuels and SARS-CoV-2 lethality in England. We compare up-to-date, real-time SARS-CoV-2 cases and death measurements from public databases to air pollution data monitored across over 120 sites in different regions. We found that the levels of some markers of poor air quality, nitrogen oxides and ozone, are associated with COVID-19 lethality in different English regions. We conclude that the levels of some air pollutants are linked to COVID-19 cases and morbidity. We suggest that our study provides a useful framework to guide health policy in countries affected by this pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work is funded by the UK Medical Research Council, intramural project MC_UU_00025/3 (RG94521).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData used for the statistical analyses will be available if requested https://www.gov.uk/government/publications/covid-19-track-coronavirus-cases https://www.england.nhs.uk/statistics/statistical-work-areas/covid-19-daily-deaths/ SARSsevere acute respiratory syndrome ER -